Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?

被引：9

作者：

Boers, M ^{[1
]}

机构：

[1] Vrije Univ Amsterdam, Ctr Med, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2004年 / 18卷 / 01期

关键词：

glucocorticoids; arthritis; rheumatoid; treatment; benefits and harms; review; scholarly;

D O I：

10.1016/j.berh.2003.10.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment of rheumatoid arthritis with glucocorticoids remains controversial despite a considerable and growing body of evidence. This chapter focuses on the research agenda in urgent need of execution: to define conclusively the benefit/harm trade-offs and pin down the place of these agents in the treatment cascade.

引用

页码：21 / 29

页数：9

共 36 条

[1] GLUCOCORTICOIDS AND INFECTION [J].

AUCOTT, JN .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (03) :655-670

[2]

Bijlsma Johannes W. J., 2002, Trends in Immunology, V23, P59, DOI 10.1016/S1471-4906(01)02128-7

[3] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].

Boers, M ;

Verhoeven, AC ;

Markusse, HM ;

vandeLaar, MAFJ ;

Westhovens, R ;

vanDenderen, JC ;

vanZeben, D ;

Dijkmans, BAC ;

Peeters, AJ ;

Jacobs, P ;

vandenBrink, HR ;

Schouten, HJA ;

vanderHeijde, DMFM ;

Boonen, A ;

vanderLinden, S .

LANCET, 1997, 350 (9074) :309-318

[4] Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis [J].

Boers, M ;

Nurmohamed, MT ;

Doelman, CJA ;

Lard, LR ;

Verhoeven, AC ;

Voskuyl, AE ;

Huizinga, TWJ ;

van de Stadt, RJ ;

Dijkmans, BAC ;

van der Linden, S .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) :842-845

[5]

Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496

[6] Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology [J].

Buttgereit, F ;

da Silva, JAP ;

Boers, M ;

Burmester, GR ;

Cutolo, M ;

Jacobs, J ;

Kirwan, J ;

Köhler, L ;

van Riel, P ;

Vischer, T ;

Bijlsma, JWJ .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (08) :718-722

[7] THE EFFICACY AND SAFETY OF LOW-DOSE CORTICOSTEROIDS FOR RHEUMATOID-ARTHRITIS [J].

CALDWELL, JR ;

FURST, DE .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 21 (01) :1-11

[8]

Carnahan M C, 2000, Curr Opin Ophthalmol, V11, P478, DOI 10.1097/00055735-200012000-00016

[9]

Criswell LA., 2000, COCHRANE DB SYST REV, V1998, pCD001158, DOI 10.1002/14651858.CD001158

[10] Use of inhaled corticosteroids and the risk of cataracts [J].

Cumming, RG ;

Mitchell, P ;

Leeder, SR .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (01) :8-14

← 1 2 3 4 →